French Auto Components Stock News

In recent days, reports indicated that France's highest civil court may rule in favour of the Bollore family in Vivendi's high-profile legal dispute with minority shareholders over the company's multibillion-euro split in 2024, following a recommendation by the advocate general to overturn a prior decision from the Paris Court of Appeal. This development introduces greater uncertainty around Vivendi's post-breakup ownership and potentially signals new directions for corporate governance and...

As an investor its worth striving to ensure your overall portfolio beats the market average. But in any portfolio...

It hasn't been the best quarter for Caisse Régionale de Crédit Agricole Mutuel de la Touraine et du Poitou Sociét...

Pernod Ricard SA ( EPA:RI ) is about to trade ex-dividend in the next three days. The ex-dividend date is two business...

STMicroelectronics N.V. ( EPA:STMPA ) shares have had a horrible month, losing 26% after a relatively good period...

To the annoyance of some shareholders, Worldline SA ( EPA:WLN ) shares are down a considerable 31% in the last month...

Key Insights Significant control over Aramis Group SAS by public companies implies that the general public has more...

As the pan-European STOXX Europe 600 Index experienced a modest rise, bolstered by the reopening of the U.S. federal government, cooling sentiment on artificial intelligence tempered broader market gains. In this environment, identifying stocks trading below their estimated worth can offer potential opportunities for investors seeking value amidst fluctuating economic conditions and investor sentiment.

Key Insights The considerable ownership by private companies in Casino Guichard-Perrachon indicates that they...

Let's talk about the popular Hermès International Société en commandite par actions ( EPA:RMS ). The company's shares...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...

Arkema S.A.'s ( EPA:AKE ) stock was strong despite it releasing a soft earnings report last week. We think that...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

EssoF (ENXTPA:ES) just announced a hefty €60.21 per share special dividend, set for November 14, 2025, after shareholders gave the green light during the recent Combined General Meeting. Investors are paying close attention. See our latest analysis for EssoF. That extraordinary dividend comes after an eventful year for EssoF, with the share price recently closing at €47.44. Despite a sharp drop in price over the past month and year-to-date, investors who held on for the past twelve months...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. One common approach is to try and...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Key Insights The projected fair value for Sopra Steria Group is €252 based on 2 Stage Free Cash Flow to Equity Sopra...

When close to half the companies in France have price-to-earnings ratios (or "P/E's") above 17x, you may consider FDJ...

With its stock down 27% over the past three months, it is easy to disregard Logic Instrument (EPA:ALLOG). However...

With a median price-to-sales (or "P/S") ratio of close to 0.3x in the Electronic industry in France, you could be...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Wendel...

The Valeo SE ( EPA:FR ) share price has done very well over the last month, posting an excellent gain of 26%. Looking...

Key Insights Cerinnov Group's estimated fair value is €0.24 based on 2 Stage Free Cash Flow to Equity With €0.25 share...

On October 31, Nanobiotix announced it had entered a royalty-based financing agreement with HealthCare Royalty to secure up to US$71 million in non-dilutive capital, supporting its operations and the advancement of nanotherapeutic platforms. This agreement signals a reinforced financial position for Nanobiotix, potentially underpinning its ability to sustain research and development initiatives over the long term. We’ll explore how this infusion of non-dilutive capital from the royalty-based...